Sign inGet started

Keresty Georgia

Insider CIK 1773532 · NTLA Director · SLDB Director · AZPN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SLDB Solid Biosciences Inc. A Award deriv2026-06-102026-06-1177,500— $077,500SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2026-06-092026-06-1013,300— $013,300SEC↗
NTLA Intellia Therapeutics, Inc A Award2026-06-092026-06-109,200— $041,083SEC↗
SLDB Solid Biosciences Inc. A Award deriv2025-06-122025-06-1877,500— $077,500SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2025-06-112025-06-1811,450— $011,450SEC↗
NTLA Intellia Therapeutics, Inc A Award2025-06-112025-06-188,000— $031,883SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2024-06-122024-06-1411,515— $011,515SEC↗
NTLA Intellia Therapeutics, Inc A Award2024-06-122024-06-147,737— $023,883SEC↗
SLDB Solid Biosciences Inc. A Award deriv2024-06-112024-06-1334,400— $034,400SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2023-06-142023-06-166,473— $06,473SEC↗
NTLA Intellia Therapeutics, Inc A Award2023-06-142023-06-164,425— $016,146SEC↗
SLDB Solid Biosciences Inc. A Award deriv2023-06-062023-06-089,650— $09,650SEC↗
SLDB Solid Biosciences Inc. A Award deriv2022-12-132022-12-159,650— $09,650SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2022-06-142022-06-167,688— $07,688SEC↗
NTLA Intellia Therapeutics, Inc A Award2022-06-142022-06-165,197— $011,721SEC↗
SLDB Solid Biosciences Inc. A Award deriv2022-06-072022-06-0951,000— $051,000SEC↗
AZPN ASPENTECH Corp D To issuer deriv2022-05-162022-05-181,531— $00SEC↗
AZPN ASPENTECH Corp D To issuer deriv2022-05-162022-05-18303— $00SEC↗
AZPN ASPENTECH Corp D To issuer deriv2022-05-162022-05-181,444— $00SEC↗
AZPN ASPENTECH Corp D To issuer deriv2022-05-162022-05-181,684— $00SEC↗
AZPN ASPENTECH Corp D To issuer2022-05-162022-05-183,465— $00SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award2022-05-122022-05-13826— $03,465SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award deriv2021-09-012021-09-031,531$129.50 $198.3K1,531SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award2021-09-012021-09-03866— $02,639SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2021-06-232022-04-142,534— $02,534SEC↗
NTLA Intellia Therapeutics, Inc A Award2021-06-232022-04-141,569— $06,524SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2021-06-232021-06-253,382— $03,382SEC↗
NTLA Intellia Therapeutics, Inc A Award2021-06-232021-06-252,094— $02,094SEC↗
NTLA Intellia Therapeutics, Inc A Award deriv2021-04-092021-04-137,755— $07,755SEC↗
NTLA Intellia Therapeutics, Inc A Award2021-04-092021-04-134,955— $04,955SEC↗
SLDB Solid Biosciences Inc. A Award deriv2021-03-022021-03-0440,000— $040,000SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award deriv2020-12-282020-12-30303$130.51 $39.5K303SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award2020-12-282020-12-30154— $01,773SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award deriv2019-09-032019-09-051,444$133.20 $192.3K1,444SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award2019-09-032019-09-05732— $01,619SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award deriv2019-04-172019-04-191,684$109.97 $185.2K1,684SEC↗
AZPN ASPEN TECHNOLOGY INC /DE/ A Award2019-04-172019-04-19887— $0887SEC↗